Exelixis Inc (EXEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt EXEL? Forum Prognose

Finanzdaten der Exelixis Inc-Aktie (EXEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-29	2023-12-29	2023-09-29	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.35% 425.23	479.65	471.92	469.85	408.79
Cost Of Revenue	2.28% 21.26	21.75	18.77	17.70	14.31
Gross Profit	11.78% 403.97	457.90	453.15	452.14	394.47
Operating Expenses	0.43% 374.51	376.11	470.73	374.29	365.64
Benefits Costs and Expenses	0.53% 395.76	397.86	489.50	392.00	379.96
Costs And Expenses	0.53% 395.76	397.86	489.50	392.00	379.96
Operating Income/Loss	63.98% 29.46	81.79	-17.58	77.85	28.83
Income/Loss From Continuing Operations Before Tax	63.98% 29.46	81.79	-17.58	77.85	28.83
Income Tax Expense/Benefit	31.80% 11.95	17.52	4.777	19.21	8.25
Income/Loss From Continuing Operations After Tax	56.36% 37.32	85.52	1.041	81.18	40.03
Net Income/Loss	56.36% 37.32	85.52	1.041	81.18	40.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9,434% 300.76	-3.222	315.50	324.20	324.42
Diluted Average Shares	10,961% 305.53	-2.813	319.25	327.31	326.28
Basic Earnings Per Share	55.56% 0.12	0.27	-	0.25	0.12
Diluted Earnings Per Share	55.56% 0.12	0.27	-	0.25	0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%